Holen Sie sich die Stockscreener-App
66.95
0.48%
-0.32
Handel nachbörslich:
67.44
0.49
+0.73%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$67.27
Offen:
$67.42
24-Stunden-Volumen:
8.05M
Relative Volume:
1.60
Marktkapitalisierung:
$25.77B
Einnahmen:
$4.66B
Nettoeinkommen (Verlust:
$836.30M
KGV:
31.99
EPS:
2.093
Netto-Cashflow:
$1.08B
1W Leistung:
+4.22%
1M Leistung:
-8.39%
6M Leistung:
-0.74%
1J Leistung:
-10.86%
1-Tages-Spanne:
$66.00
$67.91
1-Wochen-Bereich:
$64.60
$68.76
52-Wochen-Spanne:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Firmenname
Dexcom Inc
Sektor
Branche
Telefon
(858) 200-0200
Adresse
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
66.95 | 25.77B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
105.46 | 183.26B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
335.67 | 128.46B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.16 | 110.62B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.48 | 103.10B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.50 | 47.92B | 6.07B | 1.06B | 1.34B | 1.8063 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-12 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | Eingeleitet | Evercore ISI | In-line |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-09-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Eingeleitet | Argus | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Buy |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-02-03 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-03-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-01-26 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-15 | Eingeleitet | Bernstein | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-03 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-07-21 | Fortgesetzt | Cowen | Outperform |
| 2021-05-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-01-06 | Hochstufung | UBS | Neutral → Buy |
| 2020-10-02 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-11-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-11-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-10-23 | Eingeleitet | Stifel | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-10-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-09-12 | Hochstufung | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Bestätigt | Canaccord Genuity | Buy |
| 2018-07-02 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
| 2018-05-03 | Bestätigt | Canaccord Genuity | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Sell |
| 2018-04-04 | Eingeleitet | Guggenheim | Neutral |
| 2018-03-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Bestätigt | Wedbush | Outperform |
Alle ansehen
Dexcom Inc Aktie (DXCM) Neueste Nachrichten
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DexCom, Inc. (DXCM) And Encourages Stockholders to Reach Out - ACCESS Newswire
Dexcom stock falls despite Q4 earnings beat, G7 rollout drives growth - MSN
Insider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of Stock - MarketBeat
Dexcom (DXCM) legal chief sells 1,700 shares in 10b5-1 trade - Stock Titan
Mizuho Markets Cayman LP Acquires 53,093 Shares of DexCom, Inc. $DXCM - MarketBeat
CIBC Private Wealth Group LLC Acquires 2,294,709 Shares of DexCom, Inc. $DXCM - MarketBeat
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
Block Trades: Will DexCom Inc outperform the market in YEAR2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal - MSN
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Stockholders to Connect - ACCESS Newswire
DexCom, Inc. $DXCM Shares Purchased by Mizuho Markets Cayman LP - MarketBeat
Bank of Nova Scotia Trims Stake in DexCom - National Today
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia - MarketBeat
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know - Yahoo Finance
Here's why you should hold DexCom stock in your portfolio for now - MSN
[144] DEXCOM INC SEC Filing - Stock Titan
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - The Globe and Mail
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? - Yahoo Finance
Iron Triangle Partners LP Purchases New Shares in DexCom, Inc. $DXCM - MarketBeat
Holocene Advisors Invests $163.96M in DexCom - National Today
Holocene Advisors LP Makes New $163.96 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. - National Today
DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 - MSN
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM - MarketBeat
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment - The Motley Fool
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Aristotle Atlantic Partners LLC Makes New $13.01 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Is DexCom (DXCM) Fairly Priced After Recent Share Price Pullback? - simplywall.st
Prosight Management LP Boosts DexCom Stake by 178.9% - National Today
Prosight Management LP Acquires 125,217 Shares of DexCom, Inc. $DXCM - MarketBeat
Thematics Asset Management Has $24.38 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Ossiam Has $18.15 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Wealth Advisors of Tampa Bay LLC Has $660,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
Sirios Capital Management Boosts DexCom Stake by 75% - National Today
Sirios Capital Management L P Acquires 145,682 Shares of DexCom, Inc. $DXCM - MarketBeat
Assessing DexCom (DXCM) Valuation As Conference Highlights Growth In Glucose Monitoring Technology - simplywall.st
Devon Energy Corp Stock (ISIN: US2521311074) Gains Momentum Amid Oil Price Recovery - AD HOC NEWS
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
Meridiem Capital Partners LP Grows Stake in DexCom, Inc. $DXCM - MarketBeat
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Legal & General Group Plc Increases Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Swiss National Bank Trims Stake in DexCom by 4.8% - National Today
Swiss National Bank Sells 56,600 Shares of DexCom, Inc. $DXCM - MarketBeat
Mackenzie Financial Corp Raises Position in DexCom, Inc. $DXCM - MarketBeat
DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript - MSN
Capital Research Global Investors Trims Holdings in DexCom, Inc. - National Today
Capital Research Global Investors Cuts Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Finanzdaten der Dexcom Inc-Aktie (DXCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.27%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):